RECRUITING

An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this randomized trial is to test whether the Internet-Delivered Enhanced Assess, Acknowledge, Act (IDEA3) sexual assault resistance education intervention reduces sexual violence victimization in undergraduate women. Participants in the intervention group will be asked to attend four three-hour group sessions of a sexual assault resistance program called IDEA3 with a partner, as well as fill out a number of surveys. Participants in the control group will be asked to attend a one-hour consent workshop with a partner and fill out surveys. Researchers will compare sexual assault victimization between the groups in the one year following the intervention.

Official Title

A Randomized Controlled Trial of the Efficacy of IDEA3 - an Evidence-based Sexual Assault Resistance Intervention for Undergraduate Women Adapted for Internet Delivery

Quick Facts

Study Start:2023-10-02
Study Completion:2027-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06058455

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:17 Years to 24 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * 1st- and 2nd-year university students at one of the 4 sites
  2. * female-identifying students
  3. * students between ages of 17-24
  4. * able to attend one of the scheduled program groups
  5. * able and willing to be matched with another eligible student
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Sarah M Peitzmeier, PhD
CONTACT
(734) 764-4176
speitzme@umich.edu
Charlene Y Senn, PhD
CONTACT
519-253-3000
csenn@uwindsor.ca

Principal Investigator

Sarah M Peitzmeier, PhD
PRINCIPAL_INVESTIGATOR
University of Michigan
Charlene Y Senn, PhD
PRINCIPAL_INVESTIGATOR
University of Windsor

Study Locations (Sites)

University of Michigan
Ann Arbor, Michigan, 48109
United States
University of Nebraska - Lincoln
Lincoln, Nebraska, 68588
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • Sarah M Peitzmeier, PhD, PRINCIPAL_INVESTIGATOR, University of Michigan
  • Charlene Y Senn, PhD, PRINCIPAL_INVESTIGATOR, University of Windsor

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-02
Study Completion Date2027-09-30

Study Record Updates

Study Start Date2023-10-02
Study Completion Date2027-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Sexual Assault